Case Study
Q1
One of the primary risk factors for C difficile Colitis is previous exposure to antibiotics. When a person takes an antibiotic to treat an infection, these medicines tend to destroy some of the common and essential bacteria that the body requires and the bacteria causing the infection. When the body lacks enough healthy bacteria to keep it strong from diseases, Clostridium difficile can grow out of control.
Q2
One of the medications that were given to K.L. that is inappropriate is Vancomycin Oral. This medicine is an antibiotic used to treat several bacterial infections, such as treatment for complicated bloodstream infections, skin infections, and meningitis. It is also used to treat infection of the intestines. However, Vancomycin Oral only works in the intestines and will not benefit the patient (Hota et al., 2017). It is also inappropriate as it may lead to the destruction of healthy body bacteria, dangerous to the body.
Q3
The treatment of C. Difficile is another antibiotic. A doctor may prescribe fidaxomicin medication to treat the infection. If the situation is serious, such as organ failure, inflammation of the abdominal wall, surgery may be required to remove the colon’s affected portion. The antibiotics taken should ensure they treat the infection only. The patient is expected to recover within a week or two.
Q4
The treatment regimens are inappropriate for K.L. since they involve inflammation in the colon and intestines. The hospital’s recommendation to purchase oral Vancomycin medication indicates that the treatment regimen is inappropriate since the client does not suffer from colon inflammation.
Q5
K.L. should be taught lifestyle changes such as eating a low-fat and low-sodium diet. Undertake at least 30 minutes of exercise. Adopting these lifestyle changes can be therapeutic to the patient, giving the patient a better life and reduced the risks of her health deteriorating.
References
Hota, S. S., Sales, V., Tomlinson, G., Salpeter, M. J., McGeer, A., Coburn, B., … & Poutanen, S. M. (2017). Oral vancomycin followed by fecal transplantation versus tapering oral vancomycin treatment for recurrent Clostridium difficile infection: an open-label, randomized controlled trial. Clinical Infectious Diseases, 64(3), 265-271.